LYRA Lyra Therapeutics, Inc.

Fundamentals / CIK 0001327273 / USD

Lyra Therapeutics, Inc. reported $398K in revenue and a net loss of $28.92M for the fiscal year ended December 31, 2025 (down 74.1% year over year), with a -7794.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LYRA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$11.40M$5.70M$0-$87.49MFY 2019 Net Income: -$16.31M2019FY 2020 Net Income: -$22.13M2020FY 2021 Revenue: $285KFY 2021 Net Income: -$43.51M2021FY 2022 Revenue: $1.36MFY 2022 Net Income: -$55.28M2022FY 2023 Revenue: $1.56MFY 2023 Net Income: -$62.68M2023FY 2024 Revenue: $1.53MFY 2024 Net Income: -$93.44M2024FY 2025 Revenue: $398KFY 2025 Net Income: -$28.92M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $398K $1.53M $1.56M $1.36M $285K -- --
Research & Development $18.41M $43.77M $48.03M $38.80M $29.69M $12.52M $12.03M
Total Operating Expenses $31.42M $97.88M $68.68M $57.67M $43.90M $22.21M $16.52M
Operating Income -$31.02M -$96.35M -$67.12M -$56.31M -$43.62M -$22.21M -$16.52M
EBITDA -$30.56M -$95.88M -$66.84M -$55.24M -$42.61M -$22.11M -$16.49M
Interest Income $1.13M $2.95M $4.50M $1.04M $102K $82K $213K
Income Before Tax -$28.91M -$93.40M -$62.62M -$55.27M -$43.51M -- --
Income Tax Expense $11K $39K $59K $13K $0 $0 $0
Net Income -$28.92M -$93.44M -$62.68M -$55.28M -$43.51M -$22.13M -$16.31M
Basic EPS -$18.62 -$71.75 -$63.00 -$91.50 -$167.50 -$129.50 -$4,111.50
Diluted EPS -$18.62 -$71.75 -$63.00 -$91.50 -$167.50 -$129.50 -$4,111.50
Basic Shares Outstanding 1.6M 1.3M 996.1K 604.7K 259.7K 171.8K 4.0K
Diluted Shares Outstanding 1.6M 1.3M 996.1K 604.7K 259.7K 171.8K 4.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue $7.0K $25K $183K $183K $209K $195K $598K $532K
Research & Development $4.38M $4.05M $5.11M $4.88M $6.36M $5.90M $13.26M $18.24M
Total Operating Expenses $7.12M $6.26M $9.01M $9.02M $11.62M $12.64M $49.57M $24.06M
Operating Income -$7.12M -$6.24M -$8.83M -$8.84M -$11.41M -$12.44M -$48.97M -$23.52M
EBITDA -$7.02M -$6.14M -$8.63M -$8.71M -$11.26M -$12.40M -$48.77M -$23.39M
Interest Income $169K $256K $410K $298K $435K $576K $855K $1.09M
Income Before Tax -$6.95M -$5.98M -$7.43M -$8.54M -$10.97M -$11.87M -$48.12M -$22.44M
Income Tax Expense $2.0K $3.0K $2.0K $4.0K $6.0K $7.0K $12K $14K
Net Income -$6.95M -$5.98M -$7.44M -$8.55M -$10.98M -$11.87M -$48.13M -$22.45M
Basic EPS -- -$3.38 -$5.51 -$6.50 -- -$9.07 -$36.76 -$17.50
Diluted EPS -- -$3.38 -$5.51 -$6.50 -- -$9.07 -$36.76 -$17.50
Basic Shares Outstanding -- 1.8M 1.3M 1.3M -- 1.3M 1.3M 1.3M
Diluted Shares Outstanding -- 1.8M 1.3M 1.3M -- 1.3M 1.3M 1.3M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $15.89M $40.58M $22.35M $32.55M $45.75M $74.59M $9.81M
Short-Term Investments $0 $0 $80.40M $65.34M $0 -- --
Cash & Short-Term Investments $15.89M $40.58M $102.8M $97.89M $45.75M $74.59M $9.81M
Total Current Assets $16.27M $43.02M $104.8M $100.8M $47.92M $75.92M $10.12M
Property, Plant & Equipment, Net $1.05M $1.40M $2.04M $2.24M $4.50M $2.17M $237K
Other Non-Current Assets -- $0 $1.11M $3.28M $762K $118K $1.10M
Total Non-Current Assets $19.84M $23.32M $37.78M $9.14M $6.95M $4.91M $4.84M
Total Assets $36.11M $66.35M $142.6M $110.0M $54.87M $80.83M $14.96M
Accounts Payable $663K $1.18M $3.13M $2.62M $3.12M $922K $1.07M
Deferred Revenue (Current) -- $398K $1.66M $1.27M $9.79M -- --
Other Current Liabilities $518K $475K $1.23M $659K $633K $149K $110K
Total Current Liabilities $9.52M $12.63M $19.60M $14.47M $18.25M $4.88M $5.21M
Deferred Revenue (Non-Current) $11.86M $11.86M $12.14M $14.08M $1.93M -- --
Total Non-Current Liabilities $37.30M $42.12M $33.58M $14.74M $2.31M $1.45M $2.43M
Total Liabilities $46.83M $54.75M $53.18M $29.21M $20.55M $6.34M $7.63M
Total Debt (incl. Leases) $30.26M $34.38M $26.88M $2.22M $1.45M $2.44M $3.33M
Common Stock $2.0K $1.0K $57K $32K $13K $13K --
Retained Earnings -$433.7M -$404.8M -$311.4M -$248.7M -$193.4M -$149.9M -$127.8M
Accumulated Other Comp. Income -- $0 $33K $10K -- -- --
Total Stockholders' Equity -$10.72M $11.59M $89.42M $80.75M $34.32M $74.49M -$123.3M
Total Equity -$10.72M $11.59M $89.42M $80.75M $34.32M $74.49M -$123.3M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Cash & Cash Equivalents $15.89M $22.05M $29.78M $31.73M $40.58M $23.80M $31.91M $15.80M
Short-Term Investments $0 -- -- -- $0 $27.83M $35.59M $71.32M
Cash & Short-Term Investments $15.89M $22.05M $29.78M $31.73M $40.58M $51.63M $67.50M $87.12M
Total Current Assets $16.27M $23.02M $31.06M $33.91M $43.02M $54.44M $69.44M $89.44M
Property, Plant & Equipment, Net $1.05M $1.12M $1.16M $1.28M $1.40M $1.61M $1.67M $3.78M
Other Non-Current Assets -- -- -- -- $0 -- -- $683K
Total Non-Current Assets $19.84M $20.69M $21.51M $22.41M $23.32M $24.31M $25.15M $52.08M
Total Assets $36.11M $43.71M $52.57M $56.32M $66.35M $78.76M $94.58M $141.5M
Accounts Payable $663K $627K $680K $725K $1.18M $2.29M $4.97M $2.84M
Deferred Revenue (Current) -- $7.0K $32K $216K $398K $607K $814K $1.32M
Other Current Liabilities $518K -- -- -- $475K -- -- --
Total Current Liabilities $9.52M $9.48M $11.16M $11.47M $12.63M $14.95M $19.28M $18.72M
Deferred Revenue (Non-Current) $11.86M $11.86M $11.86M $11.86M $11.86M $11.86M $11.85M $11.94M
Total Non-Current Liabilities $37.30M $38.56M $39.79M $40.97M $42.12M $43.18M $44.33M $45.30M
Total Liabilities $46.83M $48.04M $50.95M $52.44M $54.75M $58.14M $63.60M $64.02M
Total Debt (incl. Leases) $30.26M $31.38M $32.48M $33.36M $34.38M $35.32M $36.75M $37.86M
Common Stock $2.0K $2.0K $2.0K $66K $1.0K $65K $65K $61K
Retained Earnings -$433.7M -$426.8M -$420.8M -$413.3M -$404.8M -$393.8M -$381.9M -$333.8M
Accumulated Other Comp. Income -- -- -- -- $0 $20K -$4.0K $25K
Total Stockholders' Equity -$10.72M -$4.33M $1.62M $3.87M $11.59M $20.62M $30.98M $77.50M
Total Equity -$10.72M -$4.33M $1.62M $3.87M $11.59M $20.62M $30.98M $77.50M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$28.92M -$93.44M -$62.68M -$55.28M -$43.51M -$22.13M -$16.31M
Depreciation & Amortization $459K $471K $278K $1.07M $1.00M $95K $27K
Stock-Based Compensation $2.33M $6.72M $5.89M $5.45M $2.77M $1.81M $244K
Change in Payables -$516K -$1.89M $450K -$2.41M $2.35M $345K -$205K
Operating Cash Flow -$28.86M -$70.01M -$63.30M -$43.38M -$25.82M -$21.14M -$13.75M
Capital Expenditure -$116K -$2.34M -$1.05M -$164K -$3.38M -$1.77M -$211K
Free Cash Flow -$28.98M -$72.35M -$64.35M -$43.55M -$29.20M -$22.92M -$13.96M
Purchases of Investments -- -$47.95M -$122.4M -$64.84M -- -- --
Investing Cash Flow -$98K $80.31M -$12.58M -$65.01M -$3.38M -$1.77M -$211K
Financing Cash Flow $4.27M $8.53M $65.69M $96.26M $359K $87.70M -$115K
Net Change in Cash -$24.68M $18.82M -$10.20M -$12.13M -$28.85M $64.78M -$14.08M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Net Income -$6.95M -$5.98M -$7.44M -$8.55M -$10.98M -$11.87M -$48.13M -$22.45M
Depreciation & Amortization $100K $100K $200K $128K $151K $39K $200K $136K
Stock-Based Compensation $562K $34K $914K $825K $1.94M $1.49M $1.12M $2.16M
Change in Payables $103K -$120K -$45K -$454K -$1.11M -$2.59M $2.38M -$560K
Operating Cash Flow -$6.07M -$7.36M -$6.59M -$8.84M -$11.35M -$16.22M -$19.98M -$22.45M
Capital Expenditure -- -- -- -- $58K -$51K -$196K -$2.15M
Free Cash Flow -- -- -- -- -$11.29M -$16.27M -$20.18M -$24.60M
Purchases of Investments -- -- -- -- $0 -$12.81M -$14.62M -$20.52M
Investing Cash Flow -- -- -- -- $28.13M $8.14M $36.18M $7.86M
Financing Cash Flow -- -- -- -- -$1.0K -$23K -$89K $8.64M
Net Change in Cash -$6.16M -$7.73M -$1.95M -$8.84M $16.78M -$8.11M $16.11M -$5.95M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -7794.5% -6280.8% -4308.1% -4131.0% -15303.5% -- --
Net Profit Margin -7266.1% -6090.9% -4023.1% -4055.6% -15267.7% -- --
Return on Equity (ROE) -- -805.9% -70.1% -68.5% -126.8% -29.7% --
Return on Assets (ROA) -80.1% -140.8% -44.0% -50.3% -79.3% -27.4% -109.0%
Current Ratio 1.71x 3.41x 5.35x 6.97x 2.63x 15.54x 1.94x
Quick Ratio 1.67x 3.21x 5.24x 6.77x 2.51x 15.27x 1.88x
Debt to Equity -- 2.97x 0.30x 0.03x 0.04x 0.03x --
Revenue Growth (YoY) -74.1% -1.5% +14.3% +378.2% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Operating Margin -7794.5% -5885.3% -5391.8% -6891.6% -6280.8% -6894.4% -5813.3% -4364.9%
Net Profit Margin -7266.1% -5491.2% -5043.6% -6711.4% -6090.9% -6635.8% -5570.9% -4099.8%
Return on Equity (ROE) -- -- -2394.3% -2054.0% -805.9% -473.4% -327.3% -88.9%
Return on Assets (ROA) -80.1% -75.4% -73.9% -141.2% -140.8% -123.9% -107.2% -48.7%
Current Ratio 1.71x 2.43x 2.78x 2.96x 3.41x 3.64x 3.60x 4.78x
Quick Ratio 1.67x 2.33x 2.67x 2.77x 3.21x 3.45x 3.50x 4.65x
Debt to Equity -- -- 20.02x 8.61x 2.97x 1.71x 1.19x 0.49x
Revenue Growth (YoY) -96.7% -87.2% -69.4% -65.6% +43.2% -64.2% +30.6% +29.8%
Source: SEC EDGAR CompanyFacts (CIK 0001327273) · from March 31, 2019 Data through December 31, 2025 · synced Nov 21, 2026, 05:15 UTC · Open in terminal